Satellos Expands Leadership Team with New CFO Appointment

Stock Information for Satellos Bioscience Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Satellos Bioscience Inc.

Satellos to Present at the CureDuchenne FUTURES National Conference
Satellos to Present at Bloom Burton & Co. Healthcare Investor Conference
Satellos to Participate in Two April Investor Conferences
Satellos Reports 2024 Financial Results and Highlights Company Progress
Satellos Presents Initial Data from the Phase 1 Trial of SAT-3247 at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
Satellos Announces Upcoming Presentation at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
Satellos Announces Completed Enrollment of all Four Multiple-Ascending Dose Cohorts for the Phase 1 Clinical Trial of SAT-3247 in Healthy Volunteers
Satellos to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.